Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-09-09T19:59:59.000Z.
Consensus retrieved: 2026-09-10T02:49:56.714Z. This records retrieval, including cache reads, rather than vendor publication. A quote earlier than this retrieval cannot support current forward valuation.
Quote observation: 2026-09-09T19:59:59.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b4a399992bd6703193924f0814cf522aafc7389420ebb7c81270b15ae10c36e0
FORWARD PE RATIO
N/A
Centene Corp.
Market Cap
$31.66B
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Centene Corp. (CNC) | $31.66B | N/A |
| DexCom, Inc. (DXCM)vs › | $31.65B | N/A |
| ResMed Inc. (RMD)vs › | $31.91B | N/A |
| Biogen Inc. (BIIB)vs › | $31.14B | N/A |
| Zoetis Inc. (ZTS)vs › | $30.74B | N/A |
| Waters Corporation (WAT)vs › | $30.28B | N/A |
| Alcon Inc. (ALC)vs › | $33.37B | N/A |
| GE HealthCare Technologies Inc. (GEHC)vs › | $29.44B | N/A |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $34.52B | N/A |
| Medline Inc. (MDLN)vs › | $28.79B | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus next-FY EPS
At today's $64.09 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $4.80 | $4.71 – $5.00 | 12 | 13.3x |
| 2027-12-31 | $5.26 | $4.92 – $6.16 | 12 | 12.2x |
| 2028-12-31 | $6.48 | $6.02 – $7.14 | 5 | 9.9x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
